Corbus Pharma (CRBP) Misses Q2 EPS by 90c
Tweet
Share
E-mailGet Alerts CRBP Hot Sheet
Join SI Premium – FREE
Corbus Pharma (NASDAQ: CRBP) reported Q2 EPS of ($0.90).
For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HSBC Downgrades China Power International (2380:HK) (CPWIF) to Hold
- HSBC Downgrades Kakao Corp. (035720:KS) to Hold
- ICICI Securities Resumes Dalmia Bharat Ltd (DALBHARA:IN) at Add (2)
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
